USPTO serial 90858178
ACCUPANEL
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- MONINGHOFF, KIM TERESA
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ACCUPANEL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Guro-gu, Seoul, KR
Guro-gu, Seoul, KR
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Andrew D. Bochner
Andrew D. Bochner BOCHNER PLLC1040 Avenue of the Americas15th FloorNew York, NY 10018Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | diagnostic kit for medical experiments comprising reagents for medical research use | ACTIVE | — |
| 005 | medical diagnostic test kits comprising medical diagnostic reagents and assays for testing of body fluids, excluding medical diagnostic reagents and assays for use in blood glucose testing and diabetes care | ACTIVE | — |
| 009 | Laboratory devices for detecting genetic sequences; diagnostic kit for medical experiments comprising microcentrifuge tubes for medical research use | ACTIVE | — |
| 010 | Medical diagnostic apparatus for testing DNA; Medical diagnostic apparatus for testing RNA; Medical diagnostic apparatus for testing cancer cells; Medical diagnostic apparatus for detecting cancer; Genetic testing apparatus for medical purposes; medical diagnostic test kit comprising tubes sold empty for collecting bodily fluids for genetic testing and detecting cancer; blood testing apparatus, excluding blood testing apparatus for use in blood glucose monitoring and diabetes care | ACTIVE | — |
| 042 | Development and test of chemical production methods; biotechnology research; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics and pharmacogenetics; Biological research and analysis; biochemical research; Research and development of new products; Pharmaceutical drug development services; Pharmaceutical research services; pharmaceutical products evaluation; Providing laboratory research and medical laboratory services in the field of gene expression; Conducting clinical trials for others; chemical analysis; chemical research | ACTIVE | — |
| 044 | Medical testing for diagnostic or treatment purposes in the field of cancer | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by NGeneBio
- Other trademarks owned by NGeneBio
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named ACCUPANEL
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 1, 2025 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Oct 1, 2025 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jun 13, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 31, 2024 | EX3G | SOU EXTENSION 3 GRANTED | — |
| May 31, 2024 | EXT3 | SOU EXTENSION 3 FILED | — |
| May 31, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 8, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 6, 2023 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Dec 6, 2023 | EXT2 | SOU EXTENSION 2 FILED | — |
| Dec 6, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 24, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 24, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 24, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 8, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 6, 2023 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jun 6, 2023 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jun 6, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 6, 2022 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Oct 23, 2022 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Aug 11, 2022 | CHPB | POST PUBLICATION AMENDMENT - ENTERED | — |
| Aug 9, 2022 | APET | ASSIGNED TO PETITION STAFF | — |
| Jul 26, 2022 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Jul 14, 2022 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Jun 14, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 14, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 25, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 9, 2022 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| May 9, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 6, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 6, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 5, 2022 | ALIE | ASSIGNED TO LIE | — |
| May 2, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 2, 2022 | GEAN | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| May 2, 2022 | GEAP | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| May 2, 2022 | EPEN | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY | — |
| May 2, 2022 | CPEA | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED | — |
| Apr 27, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 27, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 3, 2021 | NWAP | NEW APPLICATION ENTERED | — |